Ropes & Gray represented Ginkgo Bioworks in the transaction. Ginkgo Bioworks (NYSE: DNA) announced its acquisition of AgBiome’s platform assets in agricultural biologics. The assets will be integrated into...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the transaction. Ginkgo Bioworks (NYSE: DNA) announced the acquisition of Patch Biosciences, which has built an AI platform for sequence design that...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Ginkgo Bioworks on the agreement. Ginkgo Bioworks (NYSE: DNA) announced a collaboration with Pfizer (NYSE: PFE) focused on the discovery of RNA-based drug...
You must be a Standard 1 Year member to access this content.
Foley Hoag represented Ginkgo Bioworks on the deal. Ginkgo Bioworks (NYSE: DNA) (“Ginkgo”), the leading platform for cell programming and biosecurity, announced its acquisition of StrideBio’s adeno-associated...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
You must be a Standard 1 Year member to access this content.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented Ginkgo Bioworks, Inc. on the deal. Ginkgo Bioworks, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, closed a collaboration agreement with...
You must be a Standard 1 Year member to access this content.
MinterEllison advised Ginkgo Bioworks in relation to its entry into a technical development agreement with Microba Life Sciences. Microba Life Sciences (ASX: MAP), a precision microbiome...
You must be a Standard 1 Year member to access this content.
Thomson Geer advised Microba Life Sciences on the matter. MinterEllison supported Ginkgo on its participation as a cornerstone investor. Gut health business Microba Life Sciences Ltd...
You must be a Standard 1 Year member to access this content.
NautaDutilh assisted Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc. (“Ginkgo”), the organism company, announced it has signed a purchase agreement to acquire Dutch DNA Biotech...
You must be a Standard 1 Year member to access this content.
